Healthy volunteers help test new drug's safety and absorption
NCT ID NCT07297940
First seen Jan 04, 2026 · Last updated Jun 08, 2026 · Updated 18 times
Summary
This early-stage study looked at how the experimental drug DA-1229_01 is processed by the body and whether it is safe in healthy adults. Forty-two volunteers took a single dose while fasting. The goal was to measure drug levels in the blood and check for side effects, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Bumin hospital
Seoul, South Korea
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.